Ep 78: AI and Skin Cancer with Dr Philippe Lefrançois
Listen now
Description
Dr. Philippe Lefrançois returns to the podcast for another fascinating conversation about Artificial Intelligence and Dermatology. He and Kirk dive into a lively talk around his latest AI article in the JCMS titled: “The State of Artificial Intelligence in Skin Cancer Publications.“ Dr Lefrançois is an Assistant Professor in the Division of Dermatology, Department of Medicine, McGill University. He is also attending physician at the Jewish General Hospital, division of dermatology and carries out research in cutaneous oncology at the Lady Davis Institute. His co-authors in this article are Maxine Joly-Chevrier, Anne Xuan-Lan Nguyen, Laurence Liang and Michael Lesko-Krleza.This podcast is supported by an educational grant from Incyte Biosciences Canada, available through the CDA Corporate Supporter Program.  Dr Barber and his guests do not receive any financial reimbursement for the production of the podcast.For more great CDA podcasts check out Dermalogues (https://podcasts.apple.com/sa/podcast/dermalogues/id1457844673), our Residents podcast hosted by Dr Kerri Purdy.To learn more about the work of the Canadian Dermatology Association, please visit our website at dermatology.ca (dermatology.ca)JCMS Author Interviews is produced by the CDA and David McGuffin of Explore Podcast Productions in Ottawa.   Our theme music was composed by Lee Rosevere.
More Episodes
Kirk is thrilled to welcome Dr. Dominique Hanna onto the podcast for he what he describes as an inspiring conversation about an international level success story in telehealth that Canadians can be proud of. She and Kirk have a fascinating discussion about her article in the May/June issue of the...
Published 11/05/24
Dr. Reetesh Bose is Kirk Barber's guest for this fascinating and very practical discussion on the use of Intralesional 5-Fluorouracil for treating Keloids. Dr. Reetesh Bose is a dermatologist at the Ottawa Hospital and lecturer on the faculty of the University of Ottawa. In 2021, he founded...
Published 10/22/24